Isatuximab in Lung Transplant Recipients

Clinical trial NCT05862766 · WITHDRAWN

Trial details

NCT number: NCT05862766
Sponsor: NYU Langone Health
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Antibody-mediated Rejection Allosensitization

Start date: 2024-12-01
Primary completion: 2026-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.